NSE · VAISHALI
Vaishali Pharma Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,334
of 5,004 stocks
→ 01W
Peak #3,334 · 21 Sep 2026
Vaishali Pharma Limited, a microcap Healthcare business, is growing revenue at a solid clip, commands a premium earnings multiple, and posts a modest return on equity.
Market Cap
54.47 Cr
P/E Ratio
26.09
P/B Ratio
0.79
ROE
6.03%
ROCE
9.79%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 22.89 Cr | 26.93 Cr | 24.65 Cr | 33.45 Cr |
| Net Profit | 1.55 Cr | 38.09 L | 1.32 Cr | 1.19 Cr |
| EPS | 0.12 | 0.03 | 0.10 | 0.09 |
| Operating Profit | 1.93 Cr | 90.04 L | 2.32 Cr | 2.06 Cr |
Shareholding pattern
Promoter
30.54%
Public
69.46%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 15 Oct 2024 | Bonus | Bonus 1:1 |
| 15 Oct 2024 | Split | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share |
| 19 Sep 2024 | Other | Annual General Meeting |
| 22 Sep 2023 | Other | Annual General Meeting |
| 27 Dec 2022 | Other | Extra Ordinary General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.